Structure properties of SCOPARONE (cas 120-08-1): Polymorphs and cocrystals
-
Add time:08/28/2019 Source:sciencedirect.com
A comprehensive polymorph and cocrystal study for the natural pharmaceutical molecule scoparone (1) with low solubility was conducted, in which a novel polymorph B and four cocrystals, i.e. scoparone-3,5-difluorobenzoic acid (1a), scoparone-urea (1b), scoparone-pyrimethamine (1c) and scoparone-succinimide (1d), were obtained through solvent crystallization method. The scoparone polymorphs and cocrystals were characterized by powder X-ray diffraction and thermal analysis, the crystal structures of which were determined by single-crystal X-ray diffraction as well. The kinetic dissolution property of polymorphs and cocrystals was conducted in this work. The novel polymorph B is more thermodynamically stable than form A, and exhibits lower maximum dissolution concentration than that of form A. Among the cocrystals, the formation of cocrystal with urea can enhance the drug dissolution concentration compared to form A and form B.
We also recommend Trading Suppliers and Manufacturers of SCOPARONE (cas 120-08-1). Pls Click Website Link as below: cas 120-08-1 suppliers
Prev:Polarography of non-benzenoid aromatic and related substances—VI: Polarographic and spectrophotometric study of steric hindrance of coplanarity in 3-Phenylsydnone (cas 120-06-9)s☆
Next:Full paperSCOPARONE (cas 120-08-1) attenuates angiotensin II-induced extracellular matrix remodeling in cardiac fibroblasts) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research ArticleSCOPARONE (cas 120-08-1) attenuates RANKL-induced osteoclastic differentiation through controlling reactive oxygen species production and scavenging09/06/2019
- Analytical MethodsSCOPARONE (cas 120-08-1) inhibits adipocyte differentiation through down-regulation of peroxisome proliferators-activated receptor γ in 3T3-L1 preadipocytes09/05/2019
- Effects of SCOPARONE (cas 120-08-1) on dopamine release in PC12 cells09/04/2019
- Protective effects of SCOPARONE (cas 120-08-1) against lipopolysaccharide-induced acute lung injury09/03/2019
- SCOPARONE (cas 120-08-1) attenuates hepatic stellate cell activation through inhibiting TGF-β/Smad signaling pathway09/02/2019
- Full length articleSCOPARONE (cas 120-08-1) attenuates high glucose-induced extracellular matrix accumulation in rat mesangial cells09/01/2019
- SCOPARONE (cas 120-08-1) prevents IL-1β-induced inflammatory response in human osteoarthritis chondrocytes through the PI3K/Akt/NF-κB pathway08/31/2019
- Original articleTherapeutic effects of SCOPARONE (cas 120-08-1) on pilocarpine (Pilo)-induced seizures in mice08/30/2019
- Full paperSCOPARONE (cas 120-08-1) attenuates angiotensin II-induced extracellular matrix remodeling in cardiac fibroblasts08/29/2019


